Literature DB >> 24516019

Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.

Meena S Moran1, Stuart J Schnitt, Armando E Giuliano, Jay R Harris, Seema A Khan, Janet Horton, Suzanne Klimberg, Mariana Chavez-MacGregor, Gary Freedman, Nehmat Houssami, Peggy L Johnson, Monica Morrow.   

Abstract

PURPOSE: Controversy exists regarding the optimal margin width in breast-conserving surgery for invasive breast cancer.
METHODS: A multidisciplinary consensus panel used a meta-analysis of margin width and ipsilateral breast tumor recurrence (IBTR) from a systematic review of 33 studies including 28,162 patients as the primary evidence base for consensus.
RESULTS: Positive margins (ink on invasive carcinoma or ductal carcinoma in situ) are associated with a two-fold increase in the risk of IBTR compared with negative margins. This increased risk is not mitigated by favorable biology, endocrine therapy, or a radiation boost. More widely clear margins do not significantly decrease the rate of IBTR compared with no ink on tumor. There is no evidence that more widely clear margins reduce IBTR for young patients or for those with unfavorable biology, lobular cancers, or cancers with an extensive intraductal component.
CONCLUSION: The use of no ink on tumor as the standard for an adequate margin in invasive cancer in the era of multidisciplinary therapy is associated with low rates of IBTR and has the potential to decrease re-excision rates, improve cosmetic outcomes, and decrease health care costs. J Clin Oncol 32. 2014 American Society of Clinical Oncology®, American Society for Radiation Oncology®, and Society of Surgical Oncology®. All rights reserved. No part of this document may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission by the American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology.

Entities:  

Mesh:

Year:  2014        PMID: 24516019     DOI: 10.1200/JCO.2013.53.3935

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  103 in total

1.  Does Age Matter? Estimating Risks of Locoregional Recurrence After Breast-conservative Surgery.

Authors:  Gianluca Vanni; Marco Materazzo; Marco Pellicciaro; Ljuba Morando; Ilaria Portarena; Lucia Anemona; Maria Rolando D'Angelillo; Rosaria Barbarino; Agostino Chiaravalloti; Rosaria Meucci; Tommaso Perretta; Camilla Deiana; Paolo Orsaria; Jonathan Caspi; Chiara Adriana Pistolese; Oreste Claudio Buonomo
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Raman-Encoded Molecular Imaging with Topically Applied SERS Nanoparticles for Intraoperative Guidance of Lumpectomy.

Authors:  Yu Winston Wang; Nicholas P Reder; Soyoung Kang; Adam K Glaser; Qian Yang; Matthew A Wall; Sara H Javid; Suzanne M Dintzis; Jonathan T C Liu
Journal:  Cancer Res       Date:  2017-06-14       Impact factor: 12.701

3.  Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Authors:  A S Coates; E P Winer; A Goldhirsch; R D Gelber; M Gnant; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2015-05-04       Impact factor: 32.976

Review 4.  Appropriate margin for lumpectomy excision of invasive breast cancer.

Authors:  Andrea V Barrio; Monica Morrow
Journal:  Chin Clin Oncol       Date:  2016-04-07

5.  Soft Tissue Sarcomas of the Extremities: Surgical Margins Can Be Close as Long as the Resected Tumor Has No Ink on It.

Authors:  Kamran Harati; Ole Goertz; Andreas Pieper; Adrien Daigeler; Hamid Joneidi-Jafari; Hiltrud Niggemann; Ingo Stricker; Marcus Lehnhardt
Journal:  Oncologist       Date:  2017-07-24

6.  Rapid staining and imaging of subnuclear features to differentiate between malignant and benign breast tissues at a point-of-care setting.

Authors:  Jenna L Mueller; Jennifer E Gallagher; Rhea Chitalia; Marlee Krieger; Alaattin Erkanli; Rebecca M Willett; Joseph Geradts; Nimmi Ramanujam
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-22       Impact factor: 4.553

7.  Evaluation of ductal carcinoma in situ grade via triple-modal molecular imaging of B7-H3 expression.

Authors:  Sunitha Bachawal; Gregory R Bean; Gregor Krings; Katheryne E Wilson
Journal:  NPJ Breast Cancer       Date:  2020-04-29

Review 8.  Trends and controversies in multidisciplinary care of the patient with breast cancer.

Authors:  Laura S Dominici; Monica Morrow; Elizabeth Mittendorf; Jennifer Bellon; Tari A King
Journal:  Curr Probl Surg       Date:  2016-11-29       Impact factor: 1.909

Review 9.  Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: A systematic review and meta-analysis.

Authors:  Giovanni Mauri; Luca Maria Sconfienza; Lorenzo Carlo Pescatori; Maria Paola Fedeli; Marco Alì; Giovanni Di Leo; Francesco Sardanelli
Journal:  Eur Radiol       Date:  2017-01-03       Impact factor: 5.315

Review 10.  The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.

Authors:  M Luke Marinovich; Lamiae Azizi; Petra Macaskill; Les Irwig; Monica Morrow; Lawrence J Solin; Nehmat Houssami
Journal:  Ann Surg Oncol       Date:  2016-08-15       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.